Does CLEVIDIPINE Cause Infusion site extravasation? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Infusion site extravasation have been filed in association with CLEVIDIPINE (Cleviprex). This represents 2.5% of all adverse event reports for CLEVIDIPINE.
5
Reports of Infusion site extravasation with CLEVIDIPINE
2.5%
of all CLEVIDIPINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Infusion site extravasation From CLEVIDIPINE?
Of the 5 reports.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLEVIDIPINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CLEVIDIPINE Cause?
Hypoxia (23)
Ventilation perfusion mismatch (22)
Drug ineffective (20)
Hypotension (15)
Extravasation (13)
Tachycardia (11)
Off label use (10)
Atrial fibrillation (9)
Bradycardia (9)
Blood triglycerides increased (8)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which CLEVIDIPINE Alternatives Have Lower Infusion site extravasation Risk?
CLEVIDIPINE vs CLEXANE
CLEVIDIPINE vs CLINDAMYCIN
CLEVIDIPINE vs CLINDAMYCIN\CLINDAMYCIN
CLEVIDIPINE vs CLINDAMYCIN\TRETINOIN
CLEVIDIPINE vs CLIOQUINOL